Northwestern University Feinberg School of Medicine
Skip to main content

Translational Research in Malignancy Members

The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.

Beauchamp, Elspeth

Beauchamp, Elspeth

Research Associate Professor

Bio

Dr. Beauchamp's research has focused on developing drugs for non-traditional targets through inhibiting protein-protein interactions in order to affect cellular function and target cancer cells. ... [more]

Ben-Sahra, Issam

Ben-Sahra, Issam

Associate Professor

Bio

My current research is geared toward understanding the impact of metabolic pathways controlled by mTOR, a nutrient-sensing regulator of cell growth, on the properties of cells and tumors with specific... [more]

Benson III, Al B.

Bio

Al B. Benson III, MD, FACP, FASCO, is Professor of Medicine in the Division of Hematology and Oncology at Northwestern University Feinberg School of Medicine and Director for Cooperative Groups at th... [more]

Bharat, Ankit

Bio

My research is focused on lung preservation, transplant immunology and airway biology, achieved through collaboration with the Kovler Comprehensive Transplant Center and the Division of Pulmonary and ... [more]

Bonini, Marcelo

Bio

My laboratory is interested in understanding how changes in the electrochemical balance of the nucleus alters gene expression patterns.

Bowen, Randy

Bowen, Randy

Assistant Professor

Bio

My goal is to achieve novel treatments for ophthalmic cancers through integrative collaboration, bioinnovative device applications, and carefully designed clinical trials in an effort to bring hope to... [more]

Brat, Daniel

Brat, Daniel

Professor

Bio

Project 1. We investigate mechanisms of progression to glioblastoma (GBM), the highest grade astrocytoma, including genetics, hypoxia, and angiogenesis. Progression is characterized by tumor... [more]

Bulun, Serdar

Bio

I have been conducting both basic and clinical research in steroid-related aspects of human disease since 1991. I have collaborated with many groups of scientists over the past 20 years to study the r... [more]